Consider pronounces acquisition of J+D Forecasting

J+D Forecasting, a number one supplier of forecasting options for the pharmaceutical trade, is worked up to formally share the information of our acquisition by Consider, a distinguished member of the Norstella household. This monumental improvement, disclosed on January 10, 2024, marks a major chapter in our firm’s journey.

Within the midst of the dynamic pharmaceutical panorama, characterised by legislative modifications, regulatory shifts, geopolitical challenges, and patent expiries, the power to navigate uncertainties with precision is important. Recognizing the strategic significance of correct market forecasting, J+D Forecasting is thrilled to hitch forces with Consider.

The amalgamation of Consider’s world-class consensus forecasting and consulting experience, mixed with J+D Forecasting’s specialised fashions and software program delivered by revolutionary cloud-based administration and analytical options, guarantees to raise our capabilities. This partnership will empower our shoppers with much more clever and constant insights, fostering efficient collaboration throughout the pharmaceutical trade.

David James, CEO and Founding father of J+D Forecasting, expressed his optimism, saying, “The necessity for high-quality forecasting within the pharmaceutical and biotech house has by no means been greater. Bringing collectively two of probably the most revered forecasting suppliers within the trade gives huge alternatives for our prospects. I’m trying ahead to collaborating with the Consider staff and Norstella to deliver revolutionary options to the market.”

As we embark on this thrilling journey as a part of the Norstella household, J+D Forecasting stays devoted to delivering cutting-edge forecasting options that can proceed to form the way forward for the pharmaceutical trade.

Mike Gallup, CEO, Norstella mentioned: “We’re delighted to welcome the J+D Forecasting staff to the Norstella household. Their experience in growing bespoke forecasting fashions and revolutionary, intuitive options will present our prospects with an excellent wider breadth of experience and cutting-edge perception. The addition of those capabilities considerably boosts our means to assist obtain our mission of smoothing the trail of life-saving therapies from pipeline to affected person.”

About Consider

Since 1996, Consider, a Norstella firm, has supplied the life sciences trade with the info, perception and intelligence to facilitate assured choice making on high-value investments in therapies and markets. We allow our shoppers to embed our proprietary and trade knowledge into their workflows, instruments and processes to allow them to work extra successfully and effectively. For extra details about Consider, go to www.consider.com

About Norstella

Norstella consists of a number of outstanding pharmaceutical options suppliers—Citeline, Consider, MMIT, Panalgo, and The Dedham Group. United by a shared mission, to easy the trail to life-saving therapies for sufferers and suppliers. Norstella provides complete insights all through the drug improvement lifecycle, leveraging unparalleled knowledge, cutting-edge expertise, and skilled insights and consultancy. For extra info, go to Norstella.com

About J+D Forecasting

J+D work alongside Pharmaceutical Forecasters, Analysts, Enterprise Insights Managers and Advertising and marketing Departments to ship cloud-based forecast options and create efficient forecast fashions throughout a product lifecycle, that meet the wants of all inner stakeholders, from International and Regional groups by to particular person associates. They stability market complexity with revolutionary, but simple to make use of expertise, underpinned with the perfect pharmaceutical forecasting ideas.

Purchasers’ wants are central to the providers and options the create – they create options with particular enterprise wants in thoughts. With their information, expertise and keenness for innovation, they encourage confidence in pharmaceutical funding selections and form the market alongside their shoppers. Study extra at jdforecasting.com